UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 2, 2024
Accession Number:
0001214659-24-007916
Submission Type:
POS AM
CIK:
0001643918
Company Name:
Biodexa Pharmaceuticals Plc
File Number:
333-270353